Agilent showcases comprehensive cancer portfolio solutions at AACR 2023
From cancer research to diagnostic solutions
From cancer research to diagnostic solutions
The multicancer early detection platform was developed based on methylation of cell-free DNA
Improve reproducibility of in vivo studies using mouse models
Helping laboratories prepare for upgrades and avoid costly shutdowns
Simplified, standardized, and accelerated sample preparation for discovery and translational research
MRD testing without personalization and clinical utility of liquid biopsy platform demonstrated in multiple indications
TCR and CAR libraries enable comprehensive screening of combinations of custom gene parts including domains from TCRs and CARs
The new platform has been designed to enable faster analysis of PhenoCycler-Fusion data
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on spectroscopy, proteomics sample preparation, efficient, cost-effective, and value-based healthcare, and more
The new kit is designed to allow researchers to easily and consistently generate muscle from human pluripotent stem cells
Compatible with Micronic screw caps and ANSI/SLAS standards
A natural evolution from Segmented Flow Analysis techniques
Certified reference material kit in compliance with Arizona Cannabis regulations
Meet the 3D cell culture technology that is breaking boundaries in cancer research, drug discovery, and beyond
Thermo Fisher Scientific, Sony Biotechnology, and Logos Biosystems among those recognized
Chemically defined media optimized for growth and productivity of CHO cells in perfusion and batch and fed-batch bioprocesses
Validate the accuracy of your liquid handlers with actual experimental liquids
Discover the latest products that have earned Seal of Quality awards, including a never-before-seen triple platinum announcement